scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1107253008 |
P356 | DOI | 10.1186/S12885-018-4821-8 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s12885-018-4821-8 |
P932 | PMC publication ID | 6158817 |
P698 | PubMed publication ID | 30257646 |
P50 | author | André Reis | Q522465 |
Georgia Vasileiou | Q59942909 | ||
Peter A. Fasching | Q64005064 | ||
Matthias W. Beckmann | Q72940290 | ||
Arndt Hartmann | Q89782316 | ||
Michael P. Lux | Q37372079 | ||
P2093 | author name string | Cornelia Kraus | |
Steffen Uebe | |||
Christian T Thiel | |||
Juliane Hoyer | |||
Marius Wunderle | |||
P2860 | cites work | PALB2 is an integral component of the BRCA complex required for homologous recombination repair | Q24316113 |
Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods | Q25255759 | ||
Analysis of protein-coding genetic variation in 60,706 humans | Q26831376 | ||
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers | Q27851474 | ||
A method and server for predicting damaging missense mutations | Q27860835 | ||
Triple-Negative Breast Cancer | Q29391607 | ||
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm | Q29547194 | ||
"An addendum to breast cancer": the triple negative experience | Q30277052 | ||
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. | Q30432372 | ||
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. | Q31120259 | ||
A novel germline PALB2 deletion in Polish breast and ovarian cancer patients | Q33528298 | ||
Epidemiology of contralateral breast cancer | Q33766634 | ||
Frequency of BRCA1 mutation 5382insC in German breast cancer patients. | Q33853807 | ||
Breast cancer susceptibility: current knowledge and implications for genetic counselling | Q34161642 | ||
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing | Q34228853 | ||
Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer | Q34460831 | ||
MutationTaster2: mutation prediction for the deep-sequencing age. | Q52877992 | ||
Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. | Q54650919 | ||
[Possibilities of examination of familial breast cancers and ovarian cancers. Use of molecular-genetic analysis of the BRCA1 gene and the BRCA2 gene] | Q71845390 | ||
[Germ-line mutations of the BRCA1 gene in northeastern France] | Q73205554 | ||
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population | Q77523705 | ||
Immunophenotypic predictive profiling of BRCA1-associated breast cancer | Q34467646 | ||
Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information | Q34609519 | ||
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study | Q34749278 | ||
Human Splicing Finder: an online bioinformatics tool to predict splicing signals | Q34973311 | ||
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer | Q34996647 | ||
Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers | Q35665705 | ||
DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition | Q35993095 | ||
Founder mutations in BRCA1 and BRCA2 genes | Q36860233 | ||
Clinical practice. Management of an inherited predisposition to breast cancer | Q36877519 | ||
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral | Q36927199 | ||
Genetic predisposition to breast cancer: past, present, and future | Q37187786 | ||
UMD-Predictor: A High-Throughput Sequencing Compliant System for Pathogenicity Prediction of any Human cDNA Substitution | Q37345605 | ||
PALB2 links BRCA1 and BRCA2 in the DNA-damage response | Q37361223 | ||
The negative effect of triple-negative breast cancer on outcome after breast-conserving therapy | Q37858457 | ||
The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis | Q38109943 | ||
Toward better understanding of artifacts in variant calling from high-coverage samples | Q38224122 | ||
Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results | Q38812876 | ||
Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer. | Q41740523 | ||
Germline E-cadherin mutations in familial lobular breast cancer | Q42566631 | ||
Population genetics of BRCA1 and BRCA2. | Q43109039 | ||
Functional variants in NBS1 and cancer risk: evidence from a meta-analysis of 60 publications with 111 individual studies | Q43841469 | ||
The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype | Q46041916 | ||
Improved splice site detection in Genie | Q46338894 | ||
Prediction of human mRNA donor and acceptor sites from the DNA sequence | Q48219047 | ||
Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer. | Q50301520 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cancer research | Q3421914 |
P304 | page(s) | 926 | |
P577 | publication date | 2018-09-26 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria | |
P478 | volume | 18 |
Q98163397 | Breast MRI texture analysis for prediction of BRCA-associated genetic risk |
Q64102998 | Update Breast Cancer 2019 Part 1 - Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer |
Q64102991 | Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice |
Q89488563 | [Breast cancer in young women. Histological and prognostic specificities: how are they different from older women?] |
Search more.